GlassScriptPhysician profile
Cynthia P Roever
NPI 1295976702
$844.87
in general payments reported to CMS, 2019-2025
17 companies · $16.99 in 2025
The $16.99 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $37.66 · 2023: $117 · 2024: $367 · 2025: $16.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $225.61 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbvie INC. | $105.16 | 2023-2024 | Qulipta, Ubrelvy |
| Pfizer INC. | $76.36 | 2019-2024 | |
| Novo Nordisk INC | $61.43 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $55.90 | 2020-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.65 | 2019 | |
| Merck Sharp & Dohme LLC | $53.25 | 2019-2024 | Capvaxive |
| Astrazeneca Pharmaceuticals LP | $33.57 | 2024 | Airsupra, Farxiga |
| Exact Sciences Corporation | $32.97 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $27.16 | 2024 | |
| Amarin Pharma, INC. | $22.24 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.39 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.60 | 2024 | Xifaxan |
| Organogenesis INC. | $17.14 | 2019 | |
| Sumitomo Pharma America, INC. | $15.12 | 2024 | Gemtesa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $13.70 | 2024 | NP Thyroid 60 |
| Preventice Services, LLC | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Roever listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.